Readers of this blog know that I am a big proponent of cholesterol-lowering medications like Lipitor for patients at moderate to high risk of cardiovascular disease. ... They can argue that cardiovascular disease is the number one killer in the US, and
today, is the hepatic manifestation of the metabolic syndrome and is associated with sleep apnea, cardiovascular disease, and diabetes. ... Torres said, with the“ big 3” being sleep apnea, cardiovascular disease, and diabetes.
A new indication for empagliflozin (Jardiance) to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease. ... In a postmarketing clinical trial of more than 7,000 patients with type 2 diabetes
Management of dyslipidemia for cardiovascular disease risk reduction: Synopsis of the 2014 U.S. ... Cost-effectiveness of 10-year risk thresholds for initiation of statin therapy for primary prevention of cardiovascular disease.
He has hypertension. Family history does not include cardiovascular disease in any first-degree relatives. ... This question can be found in MKSAP 16 in the Cardiovascular Medicine section, item 1.
Measured outcomes included total mortality and cardiovascular disease outcomes over a four-year follow-up. ... Treatment with the blood-pressure medications reduced the risk of cardiovascular death by 18% and the all-cause risk of death by 14%.
Stop statins in patients with poor prognosis and no active cardiovascular disease. ... Hagman. In a trial of 381 adults with recent functional deterioration but no recent active cardiovascular disease, those who discontinued statin therapy had improved
QD: News Every Day--Married men without children incur cardiovascular risk. Married men who have no children have a 17% higher risk of dying from cardiovascular disease after the age of ... prior cardiovascular disease who were followed-up for an average
Nut consumption and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis.
QD: News Every Day--New statin guidelines could create 13 million more adults eligible for prescriptions
million of the 12.8 million increase occurring among adults without cardiovascular disease. ... Since the prevalence of cardiovascular disease rises markedly with age, the large proportions of older adults who would be eligible for statin therapy may be